Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors... Show more
The RSI Oscillator for BDMD moved out of oversold territory on August 06, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In of the 13 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on August 08, 2025. You may want to consider a long position or call options on BDMD as a result. In of 51 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BDMD just turned positive on August 05, 2025. Looking at past instances where BDMD's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BDMD advanced for three days, in of 80 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 50-day moving average for BDMD moved below the 200-day moving average on July 16, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BDMD broke above its upper Bollinger Band on August 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BDMD entered a downward trend on July 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.558) is normal, around the industry mean (57.882). P/E Ratio (5.592) is within average values for comparable stocks, (38.749). BDMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.696). BDMD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (1.896) is also within normal values, averaging (90.308).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BDMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Industry MedicalNursingServices
A.I.dvisor tells us that BDMD and PFSA have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDMD and PFSA's prices will move in lockstep.
Ticker / NAME | Correlation To BDMD | 1D Price Change % | ||
---|---|---|---|---|
BDMD | 100% | +7.41% | ||
PFSA - BDMD | 4% Poorly correlated | -2.00% | ||
DHAI - BDMD | 3% Poorly correlated | +0.64% | ||
ADGM - BDMD | -1% Poorly correlated | -4.81% | ||
AMIX - BDMD | -3% Poorly correlated | +2.24% |
Ticker / NAME | Correlation To BDMD | 1D Price Change % |
---|---|---|
BDMD | 100% | +7.41% |
Health Services category (441 stocks) | -0% Poorly correlated | +1.34% |
Medical/Nursing Services category (226 stocks) | -5% Poorly correlated | +1.24% |